Pharma
The EpiPen Pricing Crisis: Mylan, Heather Bresch, CVS’s Generic, and the Drug-Pricing PR Doctrine
The EpiPen pricing crisis (2016–2018) ran a 461% price increase from $94 to $608, the September 2016 Heather Bresch Congressional hearing, the CVS Adrenaclick generic response, and the drug-pricing PR doctrine that defined pharmaceutical crisis communications for the next decade.